Extended use of dimenhydrinate (Vomex a retard)
Brinkhoff, H.; Rummel, W.
Zeitschrift für Allgemeinmedizin 50(9): 456-457
1974
ISSN/ISBN: 0300-8673 PMID: 4464685 Document Number: 79558
Document emailed within 1 workday
Related Documents
Wilms, R. 1975: Experiences with Vertigo-Vomex retard in the treatment of vertigo and tinnitus Die Medizinische Welt 26(16): 785-787Skofitsch, G.; Lembeck, F. 1983: Serum levels of dimenhydrinate. Determination by HPLC with UV detection after intake of dimenhydrinate in a coated chewing gum dragee Arzneimittel-Forschung 33(12): 1674-1676
Lapka, R.; Pospísil, A.; Sedlmayer, P.; Rejholec, V.; Rezanka, V.; Smolík, S.; Franc, Z. 1985: Comparison of the biological availability of retard and non-retard lisuride tablets in dogs Ceskoslovenska Farmacie 34(1): 3-6
Gabor, M. 1976: Experience with Vomex a in endoscopy and blind liver puncture Die Medizinische Welt 27(5): 205-206
Gill, C.; Mallinson, A.I.; Longridge, N.S. 2000: Effects of dimenhydrinate on computerized dynamic posturography Journal of Otolaryngology 29(6): 337-339
Ryu, J.H.; McCabe, B.F. 1974: Effects of diazepam and dimenhydrinate on the resting activity of the vestibular neuron Aerospace Medicine 45(10): 1177-1179
Pongrojpaw, D.; Somprasit, C.; Chanthasenanont, A. 2007: A randomized comparison of ginger and dimenhydrinate in the treatment of nausea and vomiting in pregnancy Journal of the Medical Association of Thailand 90(9): 1703-1709
Czeizel, A.E.; Vargha, P. 2004: A case-control study of congenital abnormality and dimenhydrinate usage during pregnancy Archives of Gynecology and Obstetrics 271(2): 113-118
Döge, U.; Eger, K. 2007: A simple HPLC-UV method for the determination of dimenhydrinate and related substances--dentification of an unknown impurity Die Pharmazie 62(3): 174-178
Fagan, T.C.; Haggert, B.E.; Liss, C. 1994: Efficacy and tolerability of extended-release felodipine and extended-release nifedipine in patients with mild-to-moderate essential hypertension Clinical Therapeutics 16(4): 634-646
Starzycka, M.; Krukar-Bastrowa, K. 1980: Cosaldon retard in the treatment of certain maculopathies Klinika Oczna 82(6): 315-316
Schleef, G. 1970: Experiences with neuroleptic Jatroneural-retard Therapie der Gegenwart 109(5): 714 Passim
Slapke, J.; Hummel, S.; Wilke, A.; Wenz, W.; Meister, W.; Förster, R.; Wiesner, B.; Rentsch, E.; Nussbücker, B. 1988: Clinical use of theophylline retard Oranienburg Zeitschrift für Erkrankungen der Atmungsorgane 170(1): 49-53
Josefson, D. 1997: Caloric restriction may retard cancers Bmj 315(7119): 1332
Weindruch, R. 1989: How does dietary restriction retard diseases and aging? Progress in Clinical and Biological Research 287: 97-103
Heckrodt, K. 1979: Treatment of acoustic trauma with Cetal retard Medizinische Klinik Suppl: 55-56
Schwartzkopff, W.; Schilling, A.; Calder, D. 1980: Therapy of hyperlipoproteinemia type IIa, IIb and IV with Etofibrate retard Die Medizinische Welt 31(14): 515-520
Jackson, J.M.; Kircik, L.H.; Lorenz, D.J. 2013: Efficacy of extended-release 45 mg oral minocycline and extended-release 45 mg oral minocycline plus 15% azelaic acid in the treatment of acne rosacea Journal of Drugs in Dermatology: Jdd 12(3): 292-298
Hammerl, H.; Kränzl, C.; Nebosis, G.; Pichler, O.; Studlar, M. 1971: Therapy with Progressin retard. experimental studies on metabolism Münchener Medizinische Wochenschrift 113(33): 1112-1115
Koeppel, F.W. 1976: Treatment of sound perception deafness with Danaden retard Münchener Medizinische Wochenschrift 118(32-33): 1015-1016